Home > Inhibitors & Agonists > Membrane Transporter/Ion Channel > SGLT
Cat. No. Product name CAS No.
DC8186 Bexagliflozin(THR1442,EGT1442)|

Bexagliflozin is a potent and selective SGLT2 inhibitor with IC50 value of 5.6 μM /2 nM in SGLT1 /SGLT2 respectively.

1118567-05-7
DC3111 Canagliflozin

Canagliflozin is a highly potent and selective SGLT2 inhibitor for CHO-hSGLT2, CHO-rSGLT2 and CHO-mSGLT2 with IC50 of 4.4 nM, 3.7 nM and 2 nM, respectively.

842133-18-0
DC6904 DAPAGLIFLOZIN

DAPAGLIFLOZIN is a SGLT-2 inhibitor.

461432-26-8
DCAPI1573 Ipragliflozin (ASP1941)

Ipragliflozin (ASP1941) is a Novel Selective Sodium-Dependent Glucose Co-Transporter 2 Inhibitor, on Urinary Glucose Excretion in Healthy Subjects

761423-87-4
DC10765 LX-2761

LX2761 is a locally acting SGLT1 inhibitor that is highly potent in vitro and delays intestinal glucose absorption in vivo to improve glycemic control.

1610954-97-6
DC7921 Sotagliflozin (LX-4211)

LX-4211 is a potent dual SGLT2/1 inhibitor; Antidiabetic agents.

1018899-04-1
DC3108 PF-04971729 (Ertugliflozin)

PF-04971729 is a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2, is currently in phase 2 trials for the treatment of diabetes mellitus.

1210344-57-2
DC7826 Tofogliflozin hydrate

Tofogliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2).

1201913-82-7
Page 1 / Total 1 FirstPrevNextLastGoto